These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20562628)

  • 1. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia.
    Haring R; Baumeister SE; Völzke H; Dörr M; Felix SB; Kroemer HK; Nauck M; Wallaschofski H
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):86-96. PubMed ID: 20562628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality.
    Haring R; Teumer A; Völker U; Dörr M; Nauck M; Biffar R; Völzke H; Baumeister SE; Wallaschofski H
    Andrology; 2013 Jan; 1(1):17-23. PubMed ID: 23258625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register.
    Eriksson M; Zethelius B; Eeg-Olofsson K; Nilsson PM; Gudbjörnsdottir S; Cederholm J; Eliasson B
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):97-105. PubMed ID: 21354969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dislypidemia as a risk factor for cardiovascular disease].
    Anghel L; Ghiuru R; Gavrilescu CM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):977-81. PubMed ID: 21500446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prehypertension and cardiovascular risk factors in adults enrolled in a primary care programme.
    Nery AB; Mesquita ET; Lugon JR; Kang HC; de Miranda VA; de Souza BG; Andrade JA; Rosa ML
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):233-9. PubMed ID: 21450670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and lupus disease.
    Boucelma M; Haddoum F; Chaudet H; Kaplanski G; Mazouni-Brahimi N; Rezig-Ladjouze A; Brouri M; Berrah A
    Int Angiol; 2011 Feb; 30(1):18-24. PubMed ID: 21248669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.
    Zhang X; Sun Z; Zhang D; Zheng L; Li J; Liu S; Xu C; Li J; Hu D; Sun Y
    Heart Lung; 2009; 38(1):17-24. PubMed ID: 19150527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.
    Ferrières J; Bérard E; Crisan O; Bongard V
    Arch Cardiovasc Dis; 2010 May; 103(5):302-9. PubMed ID: 20619240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
    Jaussi A; Noll G; Meier B; Darioli R
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
    Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia in Shanghai, China.
    Wu JY; Duan XY; Li L; Dai F; Li YY; Li XJ; Fan JG
    Prev Med; 2010 Nov; 51(5):412-5. PubMed ID: 20817022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of dyslipidemia and its associated factors among Jordanian adults.
    Khader YS; Batieha A; El-Khateeb M; Al Omari M; Ajlouni K
    J Clin Lipidol; 2010; 4(1):53-8. PubMed ID: 21122627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
    Agledahl I; Skjaerpe PA; Hansen JB; Svartberg J
    Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study.
    Magnussen CG; Thomson R; Cleland VJ; Ukoumunne OC; Dwyer T; Venn A
    Arch Pediatr Adolesc Med; 2011 Jan; 165(1):68-76. PubMed ID: 21199983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.
    Haring R; John U; Völzke H; Nauck M; Dörr M; Felix SB; Wallaschofski H
    Gend Med; 2012 Dec; 9(6):557-68. PubMed ID: 23182129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.